The evolution of colorectal cancer genetics-Part 2

Clinical implications and applications

Andrew T. Schlussel, Ronald A. Gagliano, Susan Seto-Donlon, Faye Eggerding, Timothy Donlon, Jeffrey Berenberg, Henry T. Lynch

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The genetic understanding of colorectal cancer (CRC) continues to grow, and it is now estimated that 10% of the population has a known hereditary CRC syndrome. This article will examine the evolving surgical and medical management of hereditary CRC syndromes, and the impact of tumor genetics on therapy. This review will focus on the most common hereditary CRC-prone diseases seen in clinical practice, which include Lynch syndrome (LS), familial adenomatous polyposis (FAP) & attenuated FAP (AFAP), MutYH-associated polyposis (MAP), and serrated polyposis syndrome (SPS). Each section will review the current recommendations in the evaluation and treatment of these syndromes, as well as review surgical management and operative planning. A highly detailed multigeneration cancer family history with verified genealogy and pathology documentation whenever possible, coupled with germline mutation testing when indicated, is critically important to management decisions. Although caring for patients with these syndromes remains complex, the application of this knowledge facilitates better treatment of both individuals and their affected family members for generations to come.

Original languageEnglish (US)
Pages (from-to)336-344
Number of pages9
JournalJournal of Gastrointestinal Oncology
Volume5
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Colorectal Neoplasms
Hereditary Neoplastic Syndromes
Genealogy and Heraldry
Hereditary Nonpolyposis Colorectal Neoplasms
Adenomatous Polyposis Coli
Germ-Line Mutation
Documentation
Genetic Therapy
Neoplasms
Pathology
Therapeutics
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology

Cite this

The evolution of colorectal cancer genetics-Part 2 : Clinical implications and applications. / Schlussel, Andrew T.; Gagliano, Ronald A.; Seto-Donlon, Susan; Eggerding, Faye; Donlon, Timothy; Berenberg, Jeffrey; Lynch, Henry T.

In: Journal of Gastrointestinal Oncology, Vol. 5, No. 5, 2014, p. 336-344.

Research output: Contribution to journalReview article

Schlussel, Andrew T. ; Gagliano, Ronald A. ; Seto-Donlon, Susan ; Eggerding, Faye ; Donlon, Timothy ; Berenberg, Jeffrey ; Lynch, Henry T. / The evolution of colorectal cancer genetics-Part 2 : Clinical implications and applications. In: Journal of Gastrointestinal Oncology. 2014 ; Vol. 5, No. 5. pp. 336-344.
@article{eab078b4c6a34f89b453228530aa9ff3,
title = "The evolution of colorectal cancer genetics-Part 2: Clinical implications and applications",
abstract = "The genetic understanding of colorectal cancer (CRC) continues to grow, and it is now estimated that 10{\%} of the population has a known hereditary CRC syndrome. This article will examine the evolving surgical and medical management of hereditary CRC syndromes, and the impact of tumor genetics on therapy. This review will focus on the most common hereditary CRC-prone diseases seen in clinical practice, which include Lynch syndrome (LS), familial adenomatous polyposis (FAP) & attenuated FAP (AFAP), MutYH-associated polyposis (MAP), and serrated polyposis syndrome (SPS). Each section will review the current recommendations in the evaluation and treatment of these syndromes, as well as review surgical management and operative planning. A highly detailed multigeneration cancer family history with verified genealogy and pathology documentation whenever possible, coupled with germline mutation testing when indicated, is critically important to management decisions. Although caring for patients with these syndromes remains complex, the application of this knowledge facilitates better treatment of both individuals and their affected family members for generations to come.",
author = "Schlussel, {Andrew T.} and Gagliano, {Ronald A.} and Susan Seto-Donlon and Faye Eggerding and Timothy Donlon and Jeffrey Berenberg and Lynch, {Henry T.}",
year = "2014",
doi = "10.3978/j.issn.2078-6891.2014.068",
language = "English (US)",
volume = "5",
pages = "336--344",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "5",

}

TY - JOUR

T1 - The evolution of colorectal cancer genetics-Part 2

T2 - Clinical implications and applications

AU - Schlussel, Andrew T.

AU - Gagliano, Ronald A.

AU - Seto-Donlon, Susan

AU - Eggerding, Faye

AU - Donlon, Timothy

AU - Berenberg, Jeffrey

AU - Lynch, Henry T.

PY - 2014

Y1 - 2014

N2 - The genetic understanding of colorectal cancer (CRC) continues to grow, and it is now estimated that 10% of the population has a known hereditary CRC syndrome. This article will examine the evolving surgical and medical management of hereditary CRC syndromes, and the impact of tumor genetics on therapy. This review will focus on the most common hereditary CRC-prone diseases seen in clinical practice, which include Lynch syndrome (LS), familial adenomatous polyposis (FAP) & attenuated FAP (AFAP), MutYH-associated polyposis (MAP), and serrated polyposis syndrome (SPS). Each section will review the current recommendations in the evaluation and treatment of these syndromes, as well as review surgical management and operative planning. A highly detailed multigeneration cancer family history with verified genealogy and pathology documentation whenever possible, coupled with germline mutation testing when indicated, is critically important to management decisions. Although caring for patients with these syndromes remains complex, the application of this knowledge facilitates better treatment of both individuals and their affected family members for generations to come.

AB - The genetic understanding of colorectal cancer (CRC) continues to grow, and it is now estimated that 10% of the population has a known hereditary CRC syndrome. This article will examine the evolving surgical and medical management of hereditary CRC syndromes, and the impact of tumor genetics on therapy. This review will focus on the most common hereditary CRC-prone diseases seen in clinical practice, which include Lynch syndrome (LS), familial adenomatous polyposis (FAP) & attenuated FAP (AFAP), MutYH-associated polyposis (MAP), and serrated polyposis syndrome (SPS). Each section will review the current recommendations in the evaluation and treatment of these syndromes, as well as review surgical management and operative planning. A highly detailed multigeneration cancer family history with verified genealogy and pathology documentation whenever possible, coupled with germline mutation testing when indicated, is critically important to management decisions. Although caring for patients with these syndromes remains complex, the application of this knowledge facilitates better treatment of both individuals and their affected family members for generations to come.

UR - http://www.scopus.com/inward/record.url?scp=84995780101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995780101&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2078-6891.2014.068

DO - 10.3978/j.issn.2078-6891.2014.068

M3 - Review article

VL - 5

SP - 336

EP - 344

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 5

ER -